GlycoMimetics Stock Price (NASDAQ:GLYC)

Add to My Stocks
$14.58 $0.67 (4.82%) GLYC stock closing price Sep 18, 2018 (Closing)
Prev Close* : $13.91
Market Cap:
$598.93M
Day Low: $13.91
52 Week Low: $10.25
Open: $13.97
Volume: -
Day High: $14.66
52 Week High: $26.05
Dividend:
0.00

Latest Stock Market News

Latest Articles

GlycoMimetics News - From Partners

GLYC Stockcharts

View GLYC PE ratio, PS ratio stocks charts and compare with peers.
GLYC Chart
Note: Compare GlycoMimetics stock price history with the index and industry peers.

GlycoMimetics Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

GlycoMimetics Returns

ROE
(return on equity)
-25%

GlycoMimetics Financial Ratios

Asset Turnover
0
Receivables Turnover
-
Debt to Equity
0
Dividend Yield
-999.0000

GLYC Industry Peers

Company Price Change (%)
Durata Therapeutics (DRTX)24.160.41 (1.73%)
Vectura Gp Plc (VEGPF)0.940 (0%)
Sangamo Therap (SGMO)15.20.5 (3.4%)
Bluebird Bio (BLUE)1402.8 (2.04%)
Emisphere Tech (EMIS)2.370.02 (0.85%)
Alexion Pharma (ALXN)120.823.01 (2.55%)
Bristol-myers Squibb (BMY)61.480.18 (0.29%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 19, 2018

GlycoMimetics Inc Stock News - Partner Headlines

GlycoMimetics Financial Statements

income statement20172016201520142013
Net Sales or Revenues--20.07M15.02M3.99M
Net Income-33.28M-31.8M-12.76M-11.12M-10.6M
Total Operating Expense33.93M31.93M32.85M26.16M14.58M
View GlycoMimetics income statement
balance sheet20172016201520142013
Total Assets128.58M42.38M48.46M57.26M5.28M
Total Liabilities8.88M7.08M7.99M6.46M2.37M
Shareholders Equity119.7M35.3M40.47M50.8M2.9M
View GlycoMimetics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-0.51M-1.07M2M5.04M-5.49M
Net Cash from (used by) Operating Activities-29.76M-29.73M-8.24M-4.28M-15.53M
Increase (Decrease) in Prop Plant And Equipment-0.29M-0.7M-0.26M-0.21M-0.08M
View GlycoMimetics cash flow statement

GlycoMimetics Stock Message Board

GlycoMimetics stock gained 4.82%, and the last close price as of Sep 18, 2018 is $14.58 for GLYC stock. GlycoMimetics market capitalization is $598.93M and it represents the total market value of GLYC stock. GlycoMimetics valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that GlycoMimetics is worth a lot, it will most likely be reflected in an inflated GlycoMimetics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume number in GlycoMimetics stock quote data shows the number of shares traded. For Ex: 207,666 GlycoMimetics shares were traded as of last trading day, as seen from GlycoMimetics stock chart. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. GlycoMimetics does not pay dividends. To check the historical stock price movement, all time high, and all time low of GLYC, view GlycoMimetics stock price history.